Literature DB >> 6247434

Polyamine metabolism in MRC-5 cells infected with human cytomegalovirus.

A S Tyms, J D Williamson.   

Abstract

The rate of putrescine uptake into MRC-5 cells increased markedly following infection with human cytomegalovirus (HCMV). Enhanced incorporation occurred immediately after infection and the highest levels were attained following the production of infectious, progeny virus. Parallel kinetic changes in the utilization of radio-labelled putrescine were shown by the amounts of spermidine and spermine recovered from infected cells as radioactive derivatives. A temporal correlation was found between these changes in polyamine metabolism and the synthesis of virus DNA. Methylglyoxalbis(guanylhydrazone), an inhibitor of spermidine and spermine synthesis, did not affect virus replication if HCMV-infected cells were exposed to the inhibitor after completion of the eclipse phase of the virus growth cycle. These results show that polyamine metabolism is required only during the initial stages of HCMV replication.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247434     DOI: 10.1099/0022-1317-48-1-183

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  D,L-alpha-difluoromethylornithine inhibits human cytomegalovirus replication.

Authors:  W Gibson; R van Breemen; A Fields; R LaFemina; A Irmiere
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

2.  Synthesis of Semliki-forest virus in polyamine-depleted baby-hamster kidney cells.

Authors:  K Tuomi; A Raina; R Mäntyjärvi
Journal:  Biochem J       Date:  1982-07-15       Impact factor: 3.857

Review 3.  Diverse Functions of Polyamines in Virus Infection.

Authors:  Mason R Firpo; Bryan C Mounce
Journal:  Biomolecules       Date:  2020-04-18

4.  Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis.

Authors:  D L Taylor; L E Fellows; G H Farrar; R J Nash; D Taylor-Robinson; M A Mobberley; T A Ryder; D J Jeffries; A S Tyms
Journal:  Antiviral Res       Date:  1988-11       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.